Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: September

Staff  |  Issue: September 2014  |  September 1, 2014

An established 43-year-old female patient diagnosed with rheumatoid arthritis in multiple joints comes to the office for her first infliximab infusion. The patient had routine labs, chest X-ray and tuberculin purified protein derivative test (PPD) two weeks prior to her office visit. The patient’s lab, chest X-ray and PPD results are reviewed. Her PPD and chest X-ray are negative. She denies any fevers, cough, dyspnea or concurrent illness. She is on a nonsteroidal antiinflammatory drug, weekly methotrexate subcutaneous injections, folic acid and ranitidine. No changes were made in the patient’s medications.

Her IV port is started at 10:00 a.m. and infliximab 200 mg infusion at 10:15 a.m., which was completed at 12:25 p.m. The patient’s weight is recorded at 135 lbs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How would you code this patient encounter?

Share: 

Filed under:Billing/CodingBiologics/DMARDsConditionsDrug UpdatesFrom the CollegePractice SupportRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryBillingBiologicsCodingdruginfliximabMethotrexatePractice ManagementRheumatoid arthritisrheumatology

Related Articles

    Dermatology Case Answer B: September

    September 18, 2013

    Foot rash on man with hypertension

    Hair dye being applied to a man’s beard.

    Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

    December 18, 2019

    Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine…

    Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

    August 16, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

    Coding Corner Question

    January 1, 2010

    January’s Coding Challenge

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences